1. ALLA AKTIER
  2. NYHETER
  3. QLUCORE

Qlucore

Nyheter Qlucore Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Qlucore Diagnostics Solution for Pediatric Acute Leukemia Sold to First Customer

Qlucore is pleased to announce that its CE-marked (IVDR) diagnostic test, Qlucore Diagnostics 1.0 BCP-ALL, has been sold to its first customer. This milestone follows the successful launch at the end of February 2025.

Qlucore Diagnostics BCP-ALL is the first CE-marked (IVDR) diagnostic test specifically designed to improve the diagnosis of pediatric acute leukemia. Delivered as a software solution, it leverages AI-based machine learning to provide accurate and reliable results. Sales of Qlucore Diagnostics 1.0 for BCP-ALL commenced in Europe at the end of February 2025 and the first customer to be announced is Rigshospitalet, the largest teaching and public hospital in Denmark.
 
Improvement in diagnostics is a prerequisite for advancing precision medicine, leading to targeted therapies and better patient outcomes. Qlucore Diagnostics 1.0 for BCP-ALL is the first test from Qlucore. Development is ongoing for tests addressing lung cancer, bladder cancer and acute myeloid leukemia (AML).
 
“We are happy to announce that Rigshospitalet will be our first Qlucore Diagnostics customer. We are confident that their leadership will inspire other clinical laboratories to adopt our CE-marked diagnostic test designed to improve the diagnosis and treatment of pediatric acute leukemia,” says Carl-Johan Ivarsson, CEO of Qlucore.

Certified Advisor

FNCA Sweden AB
Web: www.fnca.se

Contacts

Press contact:
Maria Falck Miniotis, Marketing & Communications Manager
Phone: +46 (0) 736 10 26 65
Email: maria.falck@qlucore.com

Carl-Johan Ivarsson, CEO
Phone: +46 (0) 46 286 31 10
Email: carl-johan.ivarsson@qlucore.com 

About Qlucore

Qlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data generated by innovations in the fields of genomics and proteomics by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. Qlucore Omics Explorer software is a easy to use bioinformatics software for research in the life science, plant- and biotech industries, as well as in academia. Qlucore Diagnostics and Qlucore Insights are software platforms with built in AI-based machine learning for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 in Lund, Sweden and has customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Qlucore is listed on the Nasdaq First North Growth market. www.qlucore.com

Attachments

Qlucore Diagnostics Solution for Pediatric Acute Leukemia Sold to First Customer

Datum 2025-04-08, kl 13:00
Källa MFN
Bifogade filer
Qlucore Diagnostics Solution for Pediatric Acute Leukemia Sold to First Customer